SurModics to Introduce New Products at MEDICA

9 Nov 2011
Sonia Nicholas
Managing Editor and Clinical Lead

SurModics In Vitro Technologies, part of SurModics Inc, has announced that it is to showcase two new products at Medica later this month. The SurModics® Assay Diluent (Protein-Free) and BioFX® TMB Enhanced HRP Membrane Substrate, will be on display at the DIARECT/SurModics IVD booth.

The SurModics® Assay Diluent (Protein-Free), is a proprietary protein-free buffer formulation that reduces matrix interference in samples including heterophilic antibodies such as HAMA (human anti-mouse antibody) and RF (rheumatoid factor). The protein-free formulation removes any possible risk of BSA-related issues in sample quantitation. The diluent can be easily incorporated into your assay to provide more accurate results, with fewer false positive results.

BioFX® TMB Enhanced HRP Membrane Substrate has a room temperature stability of 2 years, and 4 year stability at 4°C. The substrate is ready to use with no need for mixing and shows similar sensitivity to most mid- to high-level chemiluminescent membrane substrates, without the costly equipment needed for detection.

You can visit the DIARECT/ SurModics IVD booth in Hall 1 1/E17 at the Medica exhibition in Dusseldorf, Germany, November 16-19, 2011. Alternatively, you can visit them at Booth 849, at the American Society for Cell Biology (ASCB) December 3-7 in Denver.

Links

Tags